null

FITC Anti-Mouse CD161/NK1.1 Antibody [PK136] (AGEL0484)

SKU:
AGEL0484
Product Type:
Antibody
Antibody Type:
Monoclonal Antibody
Applications:
FC
Reactivity:
Mouse
Host Species:
Mouse
Isotype:
IgG2a,k
Clone:
PK136
Conjugation:
FITC
$107 - $167
Frequently bought together:

Description

system_update_altDatasheetsystem_update_altMSDS

FITC Anti-Mouse CD161/NK1.1 Antibody [PK136]

The Mouse CD161/NK1.1 Monoclonal Antibody (FITC Conjugated) PK136 (AGEL0484) is a specialized antibody tailored for research involving CD161/NK1.1, key cell surface markers associated with natural killer (NK) cells and other immune cells. This monoclonal antibody, engineered for use in mouse samples, is conjugated with FITC for easy and efficient detection in flow cytometry and immunofluorescence applications.CD161/NK1.1 serves as a crucial marker for identifying and studying NK cells, a vital component of the innate immune system responsible for recognizing and eliminating infected or abnormal cells. By targeting this specific antigen, researchers can delve into the functions and behaviors of NK cells in various biological processes such as immune responses to pathogens, tumor surveillance, and autoimmunity.The PK136 monoclonal antibody offers high specificity and sensitivity for CD161/NK1.

1, allowing for precise detection and analysis of NK cells and other CD161/NK1.1-expressing cell populations. Its compatibility with flow cytometry and immunofluorescence techniques enables detailed characterization of immune cell subsets and facilitates in-depth investigations into the role of CD161/NK1.1 in immune responses and disease pathogenesis.With its tailored design for mouse samples and FITC conjugation for fluorescence-based assays, the Mouse CD161/NK1.1 Monoclonal Antibody (FITC Conjugated) PK136 (AGEL0484) is a valuable tool for immunologists, cell biologists, and researchers exploring the intricate mechanisms of NK cell biology, immune function, and related diseases. This antibody opens up new avenues for advancing our understanding of immune cell dynamics and developing targeted strategies for immunotherapy and disease intervention.